Opsis Therapeutics

Nick Manusos, President and CEO
Madison, WI
Opsis Therapeutics was founded in 2016 as a joint venture with FUJIFILM. We are developing advanced medicines for patients suffering from inherited retinal disease (IRD), inherited macular degenerations (IMD), and age-related macular degeneration (AMD). Our team has developed methods to manufacture authentic, highly pure, highly scalable, fully cryopreservable, and rigorously tested human photoreceptors (and RPE) that offer the potential for dramatic improvement in the care for patients suffering from permanent vision loss.

By using this website you agree to accept our Privacy Policy and Terms & Conditions